Active Ingredient History
Colostrum, or first milk, is the first form of milk produced by the mammary glands of humans and other mammals immediately following delivery of the newborn. It may be called beestings when referring to the first milk of a cow or similar animal. Most species will begin to generate colostrum just prior to giving birth. Colostrum has an especially high amount of bioactive compounds compared to mature milk to give the newborn the best possible start to life. Specifically, colostrum contains antibodies to protect the newborn against disease and infection, and immune and growth factors and other bioactives that help to activate a newborn's immune system, jumpstart gut function, and seed a healthy gut microbiome in the first few days of life. The bioactives found in colostrum are essential for a newborn's health, growth and vitality. Colostrum strengthens a baby's immune system and is filled with white blood cells to protect it from infection. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Celiac Disease (Early Phase 1)
Cerebrovascular Disorders (Phase 3)
Child (Phase 2)
Clostridium Infections (Phase 2/Phase 3)
Communicable Diseases (Phase 2)
Coronary Artery Disease (Phase 3)
COVID-19 (Phase 4)
Deficiency Diseases (Phase 3)
Enterocolitis, Necrotizing (Phase 1/Phase 2)
Fatty Liver (Phase 1/Phase 2)
Feeding and Eating Disorders (Phase 1/Phase 2)
Glutens (Early Phase 1)
Healthy Volunteers (Phase 1)
Hepatitis, Alcoholic (Phase 3)
Hepatitis B (Phase 2)
Hepatitis C (Phase 1)
HIV Infections (Phase 4)
Immune System Diseases (Phase 3)
Infant, Premature, Diseases (Phase 3)
Infections (Phase 2)
Intestinal Diseases (Phase 2/Phase 3)
Meningitis (Phase 1/Phase 2)
Myocardial Ischemia (Phase 3)
Non-alcoholic Fatty Liver Disease (Phase 1/Phase 2)
Peripheral Arterial Disease (Phase 3)
Sepsis (Phase 1/Phase 2)
Severe Acute Malnutrition (Phase 2)
Urinary Tract Infections (Phase 2)
Urologic Diseases (Phase 2)
Uterine Diseases (Phase 1/Phase 2)
Vascular Diseases (Phase 3)
Venous Thrombosis (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
